Monogram Orthopaedics, Inc. Stock

Equities

MGRM

US6097861081

Medical Equipment, Supplies & Distribution

Real-time Estimate Cboe BZX 03:47:43 2024-05-20 pm EDT 5-day change 1st Jan Change
1.995 USD -3.62% Intraday chart for Monogram Orthopaedics, Inc. +5.78% -41.57%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Take advantage of the offer
* See conditions on site
Sales 2024 * 1.11M Sales 2025 * 5.66M Capitalization 65.48M
Net income 2024 * -13M Net income 2025 * -16M EV / Sales 2024 * 59 x
Net cash position 2024 * - Net cash position 2025 * - EV / Sales 2025 * 11.6 x
P/E ratio 2024 *
-4.81 x
P/E ratio 2025 *
-4.06 x
Employees 28
Yield 2024 *
-
Yield 2025 *
-
Free-Float 62.92%
More Fundamentals * Assessed data
Dynamic Chart
Monogram Orthopaedics Inc has Changed its Name to Monogram Technologies Inc CI
Monogram Orthopaedics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Monogram Orthopaedics Inc. Provides Regulatory Update Following Meeting with FDA CI
Top Premarket Decliners MT
Monogram Orthopaedics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Monogram Orthopaedics, Inc. Elects Colleen Gray to Its Board CI
Monogram Orthopaedics, Inc. Delivers First Surgical Robot CI
Certain Common Stock of Monogram Orthopaedics, Inc. are subject to a Lock-Up Agreement Ending on 14-NOV-2023. CI
Top Premarket Decliners MT
Monogram Orthopaedics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Monogram Orthopaedics Files Shelf for Up to 6.5 Million Common Shares MT
Monogram Orthopaedics Inc. Announces Completion of the Development Phase and the Start of the Verification Phase for its Next-Generation Autonomous Surgical Robotic System CI
Monogram Orthopaedics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Monogram Orthopaedics, Inc. announced that it expects to receive $19.999997 million in funding from B. Riley Principal Capital II, LLC CI
Monogram Orthopaedics Receives Conditional Purchase Order to Begin Pilot Program With Global Distributor MT
More news
1 day-3.62%
1 week+5.78%
Current month-2.67%
1 month-9.05%
3 months-34.32%
6 months-38.54%
Current year-41.57%
More quotes
1 week
1.92
Extreme 1.92
2.20
1 month
1.82
Extreme 1.82
2.65
Current year
1.53
Extreme 1.53
4.90
1 year
1.53
Extreme 1.53
12.03
3 years
1.53
Extreme 1.53
48.99
5 years
1.53
Extreme 1.53
48.99
10 years
1.53
Extreme 1.53
48.99
More quotes
Managers TitleAgeSince
Chief Executive Officer 41 18-03-31
Founder 54 14-12-31
Director of Finance/CFO 55 22-12-31
Members of the board TitleAgeSince
Director/Board Member 68 22-10-31
Director/Board Member 60 16-03-31
Director/Board Member 68 Nov. 29
More insiders
Date Price Change Volume
24-05-20 2.01 -2.90% 25 539
24-05-17 2.07 -2.82% 34,348
24-05-16 2.13 +3.40% 50,500
24-05-15 2.06 +1.48% 51,684
24-05-14 2.03 +6.84% 56,347

Delayed Quote Nasdaq, May 20, 2024 at 03:23 pm EDT

More quotes
Monogram Technologies Inc., formerly Monogram Orthopaedics Inc., is an artificial intelligence (AI)-driven robotics company focused on improving human health, with an initial focus on orthopedic surgery. The Company is developing a product solution architecture to enable patient-optimized orthopedic implants at scale by combining three-dimensional (3D) printing, advanced machine vision, AI and robotics. Its mBos precision robotic surgical system is designed to autonomously execute optimized paths for high-precision insertion of its mPress press-fit implants. The Company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation necessary for reconstructive joint replacement procedures. The Company is also exploring other clinical and commercial applications for the mBos with mVision navigation.
Calendar
More about the company
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW